MD1682F1 - Method of immunotherapy in lingering pneumonias to children - Google Patents

Method of immunotherapy in lingering pneumonias to children

Info

Publication number
MD1682F1
MD1682F1 MD990208A MD990208A MD1682F1 MD 1682 F1 MD1682 F1 MD 1682F1 MD 990208 A MD990208 A MD 990208A MD 990208 A MD990208 A MD 990208A MD 1682 F1 MD1682 F1 MD 1682F1
Authority
MD
Moldova
Prior art keywords
pneumonias
lingering
immunotherapy
children
retrosternally
Prior art date
Application number
MD990208A
Other languages
Romanian (ro)
Other versions
MD1682G2 (en
Inventor
Marcelina Cebanovschi
Vasilos Liubov
Isaac Sroit
Elena Camas
Ala Cojocaru
Original Assignee
Inst Cercetari Stiintifice
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Cercetari Stiintifice filed Critical Inst Cercetari Stiintifice
Priority to MD99-0208A priority Critical patent/MD1682G2/en
Publication of MD1682F1 publication Critical patent/MD1682F1/en
Publication of MD1682G2 publication Critical patent/MD1682G2/en

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The invention relates to medicine, namely to pulmonology and immunology. Summary of the invention consists in the fact that the autologous lymphocytes, separated according to a density gradient and activated within three minutes in vitro with infrared rays, are retrosternally administered in the lymphotropic zone of the pulmonic system on the jugular incisure slowly during 20_30 s, 2_3 times per treatment course with an interval of 2_5 days between the doses.Claims: 1
MD99-0208A 1999-07-29 1999-07-29 Method of immunotherapy in lingering pneumonias to children MD1682G2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MD99-0208A MD1682G2 (en) 1999-07-29 1999-07-29 Method of immunotherapy in lingering pneumonias to children

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MD99-0208A MD1682G2 (en) 1999-07-29 1999-07-29 Method of immunotherapy in lingering pneumonias to children

Publications (2)

Publication Number Publication Date
MD1682F1 true MD1682F1 (en) 2001-06-30
MD1682G2 MD1682G2 (en) 2001-12-31

Family

ID=19739450

Family Applications (1)

Application Number Title Priority Date Filing Date
MD99-0208A MD1682G2 (en) 1999-07-29 1999-07-29 Method of immunotherapy in lingering pneumonias to children

Country Status (1)

Country Link
MD (1) MD1682G2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD2396G2 (en) * 2003-11-13 2004-11-30 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Method of treatment of the chronic duodenal and recidivating postoperative ulcers

Also Published As

Publication number Publication date
MD1682G2 (en) 2001-12-31

Similar Documents

Publication Publication Date Title
NO308198B1 (en) Implantable, biocompatible, immunoisolatory carrier for delivery of selected therapeutic products, as well as methods of making carriers
SG46445A1 (en) Vaccines against cancer and infectious diseases
WO1998033527A3 (en) Cancer immunotherapy with semi-allogeneic cells
DE69230506D1 (en) LYMPHOKINE GENE THERAPY FOR CANCER IN COMBINATION WITH TUMORANTIGENS
HK1025738A1 (en) Lo-cd2a antibody and uses thereof for inhibiting tcell activation and proliferation
AU1716297A (en) Patient-specific immunoadsorbers for the extracorporeal apheresis and methods for their preparation
AU621830B2 (en) Method and dosage form using an antagonist to gamma interferon to control mhc-associated autoimmune disease
MD1682F1 (en) Method of immunotherapy in lingering pneumonias to children
AU605159B2 (en) Improved mammal immunization
AU2192588A (en) Immunogenic composites capable of selectively inducing antibody production, pharmaceutical compositions employing the same and method of selectively inducing antibody production
EP0202642A3 (en) Process for the in vitro immunization of human splenocytes against tumor associated antigens
EP0282343A3 (en) Method to stimulate the immune response to specific antigens
EP0642333A4 (en) Method and composition for the treatment of disorders involving immunological dysfunction.
GR3021293T3 (en) A method of producing autoantibodies
EP0414816A4 (en) Induction of tolerance to a foreign antigen
NO930798L (en) PROCEDURE AND MEDICINE FOR TUMORS
EP0283443A3 (en) Process for extracting membrane antigens having immunogenic properties from human neoplastic cells and products thereby obtained
HK1021318A1 (en) Lo-cd2a antibody and uses thereof for inhibiting t cell activation and proliferation
AU2484488A (en) Method for the production of antigenic protein-hapten conjugates, and antibodies corresponding thereto
IL89857A0 (en) Human monoclonal antibodies specifically recognizing rabies virus hybridoma,cells producing them,pharmaceutical compositions containing them and their production
Haimovich et al. Human anti-mouse immunoglobulins in sera of patients treated chronically with monoclonal antibody-purified factor VIII
WO2001043772A3 (en) Method and device for producing an autologous immunization vaccine against cancerous diseases (tumour vaccine)
Stepanova et al. Prenatal irradiation consequences estimation in children after the Chernobyl accident
Kurpisz et al. Blast transformation of lymphocytes induced by spermatozoa obtained from spermatocoele
ZA892509B (en) Human monoclonal antibodies specifically recognizing rabies virus cells,cells producing the same,formulations containing the same and the production of all thereof

Legal Events

Date Code Title Description
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees